CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −128 | $49.41 | $6K | 28,032 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −552 | $51.30 | $28K | 27,480 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −2,333 | $52.44 | $122K | 25,147 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −5,852 | $53.40 | $312K | 19,295 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −4,748 | $54.38 | $258K | 14,547 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −1,342 | $55.32 | $74K | 13,205 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −40 | $56.19 | $2K | 13,165 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −243 | $57.70 | $14K | 12,922 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −129 | $58.93 | $8K | 12,793 |
| 2022-09-28 | Kinney Gene G. President and CEO | Option exercise · Stock Option (Right to Buy) | −16,412 | 0 | ||
| 2022-09-28 | Cooke Shane Director | Option exercise | +10,000 | $6.41 | $64K | 10,000 |
| 2022-09-28 | Cooke Shane Director | Sale | −10,000 | $48.09 | $481K | 0 |
| 2022-09-28 | Cooke Shane Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 20,000 | ||
| 2022-09-28 | COLLIER RICHARD T Director | Option exercise | +25,000 | $6.41 | $160K | 26,219 |
| 2022-09-28 | COLLIER RICHARD T Director | Sale | −25,000 | $48.09 | $1.2M | 1,219 |
| 2022-09-28 | COLLIER RICHARD T Director | Option exercise · Stock Option (Right to Buy) | −25,000 | 20,000 | ||
| 2022-09-28 | Ekman Lars Director | Option exercise | +31,666 | $6.41 | $203K | 31,909 |
| 2022-09-28 | Ekman Lars Director | Sale | −31,666 | $48.09 | $1.5M | 243 |
| 2022-09-28 | Ekman Lars Director | Option exercise · Stock Option (right to buy) | −31,666 | 63,334 | ||
| 2022-09-21 | Kinney Gene G. President and CEO | Option exercise | +2,720 | $6.41 | $17K | 15,513 |
Page 24 of 28 · 555 trades